Entering text into the input field will update the search result below

CoLucid Pharmaceuticals reports Q3 results

Nov. 09, 2016 8:13 AM ETCoLucid Pharmaceuticals (CLCD) StockBy: Niloofer Shaikh, SA News Editor
  • CoLucid Pharmaceuticals (NASDAQ:CLCD): Q3 EPS of -$0.79.
  • Cash and cash equivalents of $83.54M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
CLCD--
CoLucid Pharmaceuticals